ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Endocrinology, Diabetes Metabolism

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,285Medicare Part D Prescriptions Filled, Including Refills

Rank: 10 out of 274

$1.47M Total Retail Price of All Prescriptions

Rank: 6 out of 274

730 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
74% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

2% of this provider’s 730 patients filled at least one prescription for a schedule three drug, compared to an average of 2%.

Risky Drugs to Seniors

4% of this provider’s 8,625 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

68% of this provider’s prescriptions were for brand-name drugs, compared to an average of 50%.

Prescription Price

$143 was the average price of a prescription from this provider, compared to $132 among peers.

Prescriptions per Patient

14 is the average number of prescriptions (including refills) per patient, compared to an average of 10.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
NOVOLOG MIX 70-30 859 727 10 1 31
CRESTOR 838 736 2 17
LEVOTHYROXINE SODIUM 752 667 3 1
JANUVIA 744 682 4 10
JANUMET 677 528 5 22
SYNTHROID 636 565 6 2
INSULIN SYRINGE 394 334 7 9
NOVOLOG MIX 70-30 FLEXPEN 289 226 10 8 25
GLYBURIDE-METFORMIN HCL 265 255 R 9 40
METFORMIN HCL 239 193 10 3
PEN NEEDLE 234 178 11 4
KOMBIGLYZE XR 202 147 10 12 85
SIMVASTATIN 194 148 13 8
ACTOS 188 178 14 29
NATEGLINIDE 170 152 15 56
SURE COMFORT 158 142 16 49
LYRICA 145 97 17 78
LANTUS 142 106 18 7
ACTOPLUS MET 141 125 19 126
NOVOLOG 134 83 20 13
NOVOLOG FLEXPEN 123 79 21 12
METHIMAZOLE 122 103 22 19
LANTUS SOLOSTAR 113 79 23 6
GLIMEPIRIDE 112 105 24 5
LEVEMIR 108 89 25 39
LISINOPRIL 92 59 26 14
LEVEMIR FLEXPEN 83 69 27 23
ONGLYZA 77 70 28 33
ATORVASTATIN CALCIUM 74 68 29 20
NEXIUM 71 34 30 61
VICTOZA 3-PAK 69 23 31 42
GABAPENTIN 64 50 32 30
GLIPIZIDE 61 61 33 18
TRICOR 59 47 34 90
HUMALOG MIX 75-25 56 44 35 26
PIOGLITAZONE HCL 55 52 R 36 85
OMEPRAZOLE 54 54 37 32
HUMALOG 50 48 38 11
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 1, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.